Peer Review History
| Original SubmissionDecember 11, 2023 |
|---|
|
PONE-D-23-40581Oropharyngeal morphology (modified Mallampati classification) could be a useful screening tool for the risk of pneumonia in the older adultsPLOS ONE Dear Dr. FUKUDA, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Feb 23 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Fentahun Adane Nigat, MSc., PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. In the online submission form, you indicated that [Insert text from online submission form here]. All PLOS journals now require all data underlying the findings described in their manuscript to be freely available to other researchers, either 1. In a public repository, 2. Within the manuscript itself, or 3. Uploaded as supplementary information. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If your data cannot be made publicly available for ethical or legal reasons (e.g., public availability would compromise patient privacy), please explain your reasons on resubmission and your exemption request will be escalated for approval. Additional Editor Comments: Dear Authors, I have reviewed the manuscript titled "Oropharyngeal morphology (modified Mallampati classification) could be a useful screening tool for the risk of pneumonia in the older adults" (Manuscript Number: PONE-D-23-40581) and have some questions and comments for the authors. General basic Questions: 1. What specific criteria were used in the modified Mallampati classification to assess oropharyngeal morphology? 2. How was dysphagia assessed using the repetitive saliva swallowing test (RSST)? Can you provide more details about the RSST? 3. Were there any specific inclusion or exclusion criteria for the recruitment of the 191 older participants? 4. What statistical methods were employed to analyze the data and determine the correlation between the modified Mallampati classification and aspiration pneumonia? 5. Were there any limitations or potential confounding factors in the study design that could have influenced the results? Section specific questions: 6. Abstract: Could you provide more information about the specific methods used to assess oropharyngeal morphology and hyoid bone position? Additionally, please clarify the criteria used to define dysphagia and aspiration pneumonia. 7. Results: The correlation between the modified Mallampati classification and a medical history of aspiration pneumonia is mentioned. However, it would be helpful to include the strength of this correlation (e.g., correlation coefficient or p-value) to better understand the relationship. 8. Results: The lack of significant association between the Mallampati classification and the repetitive saliva swallowing test (RSST) or history of choking/gag reflex is intriguing. Are there any potential explanations for this finding? If so, please discuss them. 9. Discussion: It would be valuable to provide a more detailed discussion on the clinical implications of using the modified Mallampati classification as a screening tool for aspiration pneumonia. How might this classification be integrated into routine clinical practice? Are there any limitations or potential challenges in implementing this screening method? 10. Funding Disclosure: The manuscript states that the authors received no specific funding for this work. However, it would be helpful to clarify whether there were any sources of funding that indirectly supported the study or the authors' involvement. 11. Competing Interests: The authors have declared no competing interests. It would be beneficial to include a statement explaining that none of the authors have any financial or non-financial relationships that could be perceived as potentially influencing the interpretation of the results or biasing the study. 12. Ethics Statement: The manuscript mentions that the research was approved by the Ethics Committee. Please provide more details regarding the specific ethics approval, such as the name of the committee, the approval number, and any relevant ethical considerations that were addressed. 13. General: Please consider providing additional information regarding the demographic characteristics of the study participants, such as age range, gender distribution, and any relevant comorbidities. This information would help readers better understand the generalizability of the study findings. 14. Language and Clarity: Some sections of the manuscript could be further clarified to improve readability and understanding. I recommend a thorough proofreading to ensure accurate grammar, sentence structure, and scientific terminology throughout the manuscript. 15. Figures and Tables: Are there any figures or tables included in the manuscript to visually support the results or enhance the understanding of the study? If not, I suggest considering the inclusion of relevant visual aids to complement the text. 16. Please address these questions and comments in your revised manuscript. Comments: 1. The abstract provides a clear overview of the study objectives and methods. 2. The results indicating a significant correlation between the modified Mallampati classification and a medical history of aspiration pneumonia are interesting. However, it would be helpful to discuss the clinical implications of this finding in more detail. 3. It would be beneficial to include a discussion on the potential applications of the modified Mallampati classification as a screening tool for dysphagia and aspiration pneumonia in clinical practice. 4. Providing additional information on the demographic characteristics of the study participants, such as age distribution and gender ratio, would enhance the understanding of the study population. 5. Consider discussing the limitations of using self-reported history of choking or coughing reflex as a measure of aspiration signs, as this may introduce recall bias. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: I would like to express sincere thanks for the study you have done. Your contribution to evidence-based public health intervention is substantial, particularly in the context of the elderly population. However, I would like to request a major revision to your work. Reviewer #2: Dear Editorial Team, - I sincerely appreciate you providing me the opportunity to review this significant scientific paper. - I express my gratitude to the authors for their excellent work in examining the risk of pneumonia through non-invasive procedures, considering modifications in the morphology of the oropharynx and the position of the hyoid bone. General comments - The work could improve clinical practices and is crucial for the management of elderly patients. - The writing is excellent, and the arrangement follows scientific guidelines. Specific comments 1. Title: The title is informative and lucid. 2. Abstract: nicely put. However, the sampling strategy is left out. Add the sampling technique now. 3. Introduction: The writing is well done 4. Methods - According to the authors, all research-related surveys were completed between May 16, 2021, and June 15, 2022. What makes the addition of one month (May 16, 2022 to June 15, 2022) noteworthy? The study took place between May 16, 2021 and May 15, 2022, if it was to last a full year. - The study included 191 participants in total. What technique was used for sampling? The information was gathered at eleven hospitals. What percentage of participants was each hospital expected to contribute? Or was it just that any number of recruited subjects was employed in the research? - The study included people who were 65 years of age or older as participants. Why should you use people who are 65 years of age or older? Why not sixty or fifty? or somebody else? - Addition of dependent and independent variables was anticipated by the authors. - Addition of operational definitions is necessary. 5. Results - Well written 6. Discussion - The findings of the study are well discussed with other studies. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Bickes Wube Sume Reviewer #2: Yes: Hussen Abdu ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Screening of Aspiration Pneumonia using the Modified Mallampati Classification Tool in Older Adults PONE-D-23-40581R1 Dear Dr. FUKUDA, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Sethu Thakachy Subha, M.S Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Dear editor, all of my comments and questions were addressed. I think this manuscript is feasible for publication. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Bickes Wube Sume ********** |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .